Successful treatment of neuroblastoma in a newborn baby
https://doi.org/10.21508/1027-4065-2021-66-5-194-197
Abstract
Neuroblastoma is a malignant embryonic tumor of childhood originating from progenitor cells of the sympathetic nervous system. It accounts for 50% of all tumors in the first year of life with a high mortality rate. The development of the tumor process in this nosology is based on genetic disorders that may be associated with segmental breakdowns in chromosomes or a change in their number. The presence of aberrations of 1p and 11q loci serves as a criterion for determining the risk group, and amplification of the NMYC oncogene is an indicator of the aggressiveness of the disease. The main cause of death in neuroblastoma is hepatomegaly as a result of liver metastasis and the development of severe life-threatening complications. The presented case demonstrates a positive outcome of the disease in a newborn child with prognostically unfavorable factors, with early complex treatment, including polychemotherapy, surgical removal of the tumor and bone marrow transplantation.
About the Authors
N. Kh. Gabitova
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
I. N. Cherezova
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
I. V. Osipova
Children’s Republican Clinical Hospital
Russian Federation
Russian Federation
Kazan
References
1. Kachanov D.Yu., Tamazyan G.V., Kryuchko N.V., Dobrynina Yu.V. Malignant neoplasms in children of the first year of life. Voprosi gematologii/oncologii i immunopatologii v pediatrii 2010; 1(9): 14–22. (in Russ.)
2. Park J.R., Eggert A., Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am 2010; 24: 65–86
3. Park J.R., Bagatell R., London W.B., Maris J.M., Cohn S.L., Mattay K.K., Hogarty M.; COG Neuroblastoma Committee. Children’s Oncology Group’s 2013 blueprint for research: neuroblastoma. Pediatr Blood Cancer 2013; 60(6): 985–993. DOI: 10.1002/pbc.24433
4. Tulla M., Berthold F., Graf N., Rutkowski S., von Schweinitz D., Spix C., Kaatsch P. Incidence, trends, and survival of children with embryonal tumors. Pediatrics 2015; 3(136): 623–632. DOI: 10.1542/peds.2015-1224
5. Hero B., Berthold F. Neuroblastom. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie. 2019. http://kinderkrebsinfo.de
6. Schleiermacher G., Mosseri V., London W.B., Maris J.M., Brodeur G.M. et al. Segmental chromosomal changes have a predictive effect on neuroblastoma: a report from the INRG project. Br J Cancer 2012; 107(8): 1418–1422. DOI: 10.1038/bjc.2012.375
7. Depuydt P., Boeva V., Hocking T.D., Kannudt R., Ambros I.M., Ambros P.F. et al. Genomic Amplifications and Distal 6p Loss: New Markers of Poor Survival in High-Risk Neuroblastoma Patients. J Natl Cancer Inst 2018; 110(10): 1084–1093. DOI: 10.1093/jnci/djy 022
8. Yue Z.X., Xing T.Y., Gao C., Liu S.G., Zhao W., Zhao Q. et al. MYCN Amplification Predicts Poor Prognosis Based on In Situ Interphase Fluorescence Hybridization Analysis of Bone Marrow Cells in Neuroblastoma Metastases to the Bone Marrow. Cancer Cell Int 2017; 17: 43. DOI: 10.1186/s12935-017-0412-z
9. Yue Z.X., Xing T.Y., Gao C., Liu S.G., Zhao W., Zhao Q. et al. Deletion of chromosome 11q23 band predicts poor prognosis in patients with metastatic neuroblastoma in the bone marrow without MYCN amplification Cancer Commune (London) 2019; 39(1): 68. DOI: 10.1186 / s40880-019-0409-1
10. Kugeiko T.B., Zborovskaya A.A., Begun I.V., Proleskovskaya I.V., Aleinikova O.V., Bydanov O.I. Epidemiology and treatment results for neuroblastoma in children in the Republic of Belarus for the period 2002–2011. Voprosi gematologii i immunopatologii v pediatrii 2013; 3(12): 15–22. (in Russ.)
11. Morgenstern D., London W.B., Stevens D., Volchenbum S.L., Simon T., Nakagavara A. et al. Prognostic value of nature and the burden of metastatic disease in patients with neuroblastoma stage 4: A study from the database of the International Neuroblastoma Risk Group. Eur J Cancer 2016; 65: 1–10. DOI: 10.1016/j.ejca.2018.06.005
12. Kirilova O.A., Volkova L.D., Mikhailova E.V., Zakharova E.V., Polyakov V.G., Kazantsev A.P. Clinical features and radiation diagnostics of intraparavertebral neuroblastoma in children. Onkopediatriya (Oncopediatrics) 2015; 2(2): 121–130. DOI: 10.15690/onco.v2I2.1343. (in Russ.)
13. Berthold F. NB2004 Trial Protocol for Risk Adapted Treatment of Children with Neuroblastoma Principal investigator [Electronic resource]. 2004. URL: http://nodgo.org/sites/default/files/protokol_neuroblastoma-1.pdf (accessed: 12.12.2019.)
Review
For citations:
Gabitova N.Kh., Cherezova I.N., Osipova I.V. Successful treatment of neuroblastoma in a newborn baby. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2021;66(5):194-197. (In Russ.) https://doi.org/10.21508/1027-4065-2021-66-5-194-197
Views:
448
Email this article 